Bestevia Reb M is produced via an enzymatic conversion process using natural steviol glycosides derived from the stevia leaf.
Photo © iStockphoto.com/dirkr
Bestevia, a Reb M stevia sweetener from SweeGen (Rancho Santa Margarita, CA), has received a Generally Recognized as Safe (GRAS) “no objections” letter from FDA. The announcement was made by SweeGen together with Ingredion Inc. (Westchester, IL), which is the exclusive global distributor for SweeGen (except in China, where it is a non-exclusive distributor).
According to the companies, Bestevia Reb M is produced via an enzymatic conversion process using natural steviol glycosides derived from the stevia leaf. SweeGen says that it “is the first sweetener of its type to be made commercially available via bioconversion.”
In addition, SweeGen reports that Bestevia finally went commercial in February, and that the company has received positive feedback, including from “a major global beverage company that recently used SweeGen’s Bestevia Reb M in its large-scale trial for one of its bottled beverages.”
As a Reb M glycoside, SweeGen is said to have a clean, sweet taste comparable to regular table sugar that sidesteps any bitterness associated with other steviol glycosides. “Food and beverage manufacturers are now able to reduce a high percentage of sugar without sacrificing taste,” said Oscar Gutierrez, senior global director, sweetness innovation, Ingredion, in a press release.
Ingredion will now distribute Bestevia in the United States and Canada and plans to expand to other countries pending additional regulatory approvals. The new GRAS affirmation confirms Bestevia’s use as a general-purpose sweetener for food and beverage applications in the United States.
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.
Innophos launches phosphate blend that increases efficiency of brine pickup for poultry
July 12th 2024According to the company, when used in poultry, OptiBind can help processors increase brine pickup by 19% compared to sodium tripolyphosphate to increase their products’ juiciness and flavor, as well as ensure higher cook yield after storage.